Cited by 80Reproductive Health and ContraceptionAcute Ischemic Stroke ManagementMenopause: Health Impacts and Treatments

Current use of oral contraceptives and the risk of first-ever ischemic stroke: A meta-analysis of observational studies

Xu, Zhenlin, Li, Ying, Tang, Shaowen, Huang, Xiaoping, Chen, Tong·2015·Thrombosis Research

Abstract

Objective To evaluate the risk of first-ever ischemic stroke associated with current use of oral contraceptive pills (OCPs), and to describe how the risk was influenced by estrogen dose, progestin type, and study characteristics.Methods We obtained relevant articles published between 1970 and March 2014 by conducting a search of Pubmed, Embase and the Cochrane Library. Two investigators independently identified eligible studies based on selection criteria in a two-step method. The quality of studies was assessed with the Newcastle-Ottawa scale. Pooled odds ratios were calculated with a random-effects meta-analysis model.Results A total of 18 independent studies (3 cohort studies and 15 case-control studies) were identified. The overall summary odds ratio for first-ever ischemic stroke risk associated with current OCP use compared with noncurrent OCP use was 2.47 [95% confidence interval (CI), 2.04-2.99]. The risk of ischemic stroke among current OCP users decreased significantly with decreasing estrogen dose: OCPs of ≥50μg ethinyl estradiol (EE), 30-40 ug EE, 20 ug EE and progestin only pills implied odds ratios of 3.28 (95%CI, 2.49-4.32), 1.75 (95%CI, 1.61-1.89), 1.56 (95%CI, 1.36-1.79), and 0.99 (95%CI, 0.71-1.37), respectively. All four generations of progestin were associated with an elevated risk of ischemic stroke, and the risk of ischemic stroke among users of the fourth-generation progestins seemed to be slightly lower than those of other generations of progestins.Conclusions Data from observational studies suggest that current use of modern OCPs is associated with an increased risk of first-ever ischemic stroke. OCPs containing lower estrogen doses incline to contribute to a smaller elevated risk of ischemic stroke.

Integrity signals

Registry

Crossref · 10.1016/j.thromres.2015.04.021

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Xu, Z., Li, Y., Tang, S., Huang, X., & Chen, T.
Affiliations
  • Nanjing Medical University (CN)
  • Ningbo Center for Disease Control and Prevention (CN)
Corresponding author
Li, Ying
Venue
Thrombosis Research
Publisher
Elsevier BV
Published
2015-07
Volume
136
Issue
1
Pages
52-60
ISSN
0049-3848 (ISSN-L)
OpenAlex
W1991633668
Cited by
80
References
50
Citations by year
2026: 7 · 2025: 10 · 2024: 10 · 2023: 6 · 2022: 9 · 2021: 5 · 2020: 9 · 2019: 4 · 2018: 3 · 2017: 9 · 2016: 7 · 2015: 1
FWCI
0.96
Type
journal article
Language
en
Open access
closed
Locations
  • Thrombosis Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (30972542, BM2012062)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
oral contraceptives, ischemic stroke, estrogen dose, ethinyl estradiol, progestins, stroke risk, hormone replacement therapy
MeSH terms
Brain Ischemia, Contraceptives, Oral, Estrogens, Female, Humans, Progestins, Risk Factors, Odds Ratio, Stroke, Observational Studies as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review